Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-03-20 to 2023-04-04
Current total value of award: $1751.88
Description: 8509775476!HUMAN PAPILLOMAVIRU